MARKET

ONC

ONC

BeOne Medicines Ltd.
NASDAQ
366.73
-5.76
-1.55%
After Hours: 366.73 0 0.00% 19:30 08/28 EDT
OPEN
369.13
PREV CLOSE
372.49
HIGH
372.00
LOW
364.73
VOLUME
341.59K
TURNOVER
--
52 WEEK HIGH
385.22
52 WEEK LOW
253.95
MARKET CAP
41.70B
P/E (TTM)
64.61
1D
5D
1M
3M
1Y
5Y
1D
Generative "AI" Macro Data Shows U.S. Impacts
NASDAQ · 2d ago
Here are the major earnings after the close Thursday
Seeking Alpha · 2d ago
How Investors Are Reacting To BeOne Medicines (ONC) First-Line HER2-Positive GEA Immunotherapy Approval
Simply Wall St · 2d ago
BeOne Medicines (ONC) Wins FDA Approval In First Line HER2 Positive GEA
Simply Wall St · 4d ago
Jazz Pharmaceuticals Wins FDA Approval For Two Advanced Gastric Cancer Regimens
Benzinga · 4d ago
Jazz wins FDA nod for cancer therapy developed with BeOne, Zymeworks
Seeking Alpha · 4d ago
BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA
TipRanks · 4d ago
Zymeworks says partner Jazz receives FDA approval for Ziihera regimens
TipRanks · 4d ago
More
About ONC
BeOne Medicines AG, formerly BeiGene, Ltd., is a global oncology company engaged in discovering and developing treatments for cancer patients worldwide. With a portfolio spanning hematology and solid tumors, the Company is engaged in the development of its diverse pipeline of novel therapeutics. Its products include Brukinsa, Tevimbra and Pamiparib. Brukinsa is an orally available, small-molecule inhibitor of Bruton’s tyrosine kinase (BTK). Tevimbra is a humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high affinity and binding specificity against PD-1. It is designed to minimize binding to Fc-gamma (Fcy) receptors on macrophages, helping the body’s immune cells detect and fight tumors. The Company’s product pipeline in development includes Sonrotoclax, Tarlatamab, Zanidatamab, Blinatumomab, BGB-26808, BGB-R046, BG-68501, BG-C9074, BGB-43395, Xaluritamig, and others.

Webull offers BeOne Medicines AG (ADR) stock information, including NASDAQ: ONC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ONC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ONC stock methods without spending real money on the virtual paper trading platform.